Here, we initially found that high levels of CTBP1-AS2 can be used as a molecular marker for worse survival of patients with CRC, and its overexpression accelerates CRC cell proliferation and invasion and inhibits cell apoptosis. This evidence concerns the gene CTBP1 and colorectal carcinoma.